# Ascension Health – FDA Inspection, Nov 9, 2017

Source: https://www.keypedia.com/records/fda_inspections/ascension-health/dd1414d3-c897-4e82-bbdd-5551cea1c14e
Source feed: FDA_Inspections

> FDA inspection 1031267 of Ascension Health, November 09, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 56. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031267
- Company Name: Ascension Health
- Inspection Date: 2017-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1338156 - 2026-09-24
- [FDA Inspection 1210619 - 2023-07-24](https://www.keypedia.com/records/fda_inspections/ascension-health/fb3128f1-ad04-4909-8350-44d1222e60e7)
- [FDA Inspection 874819 - 2014-04-10](https://www.keypedia.com/records/fda_inspections/ascension-health/eb564150-25ce-4be4-940a-55d3e7e31783)
- FDA Inspection 564155 - 2009-02-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/denise-l-burosh/075a442f-67e0-4a65-9c09-e8819a329773)

Company: https://www.keypedia.com/companies/ascension-health/71f9112d-2b68-4241-b3a2-f5a476e1829a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c